Other human tumor types have also been reported to harbor ERBB2 amplification or overexpression, including lung cancers (Pellegrini et al., 2003; Langer et al., 2004), gastric cancers (Tanner et al., 2005; Bang et al., 2010), ovarian cancers (Tuefferd et al., 2007; Vermeij et al., 2008), prostate cancers (Minner et al., 2010), salivary gland tumors (Cornolti et al., 2007), and bladder cancers (Lae et al., 2010). The gene discussed is ERBB2; the disease is prostate carcinoma.